Dendritic cells in antifungal immunity and vaccine design.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 3401965)

Published in Cell Host Microbe on May 17, 2012

Authors

René M Roy1, Bruce S Klein

Author Affiliations

1: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

Associated clinical trials:

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection | NCT01067131

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection | NCT00124215

Articles citing this

C-type lectin receptors orchestrate antifungal immunity. Nat Immunol (2012) 1.89

Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog (2014) 1.39

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges. Front Microbiol (2012) 0.96

Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses. Nat Immunol (2015) 0.92

Fungal pathogens-a sweet and sour treat for toll-like receptors. Front Cell Infect Microbiol (2012) 0.92

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLoS Pathog (2015) 0.87

The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). Virulence (2012) 0.86

Exciting developments in the immunology of fungal infections. Cell Host Microbe (2012) 0.85

The cell biology of the innate immune response to Aspergillus fumigatus. Ann N Y Acad Sci (2012) 0.84

Antifungal Th Immunity: Growing up in Family. Front Immunol (2014) 0.83

Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections. MBio (2016) 0.81

Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii. Infect Immun (2015) 0.80

Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity? Front Microbiol (2012) 0.80

Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection. PLoS One (2015) 0.77

Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro. Immunol Res (2015) 0.75

Immune Response to Coccidioidomycosis and the Development of a Vaccine. Microorganisms (2017) 0.75

New insights on the development of fungal vaccines: from immunity to recent challenges. Mem Inst Oswaldo Cruz (2015) 0.75

Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant. Evid Based Complement Alternat Med (2013) 0.75

Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis. Front Microbiol (2017) 0.75

Articles cited by this

Dendritic cells and the control of immunity. Nature (1998) 56.54

Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56

Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88

Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46

Immune recognition. A new receptor for beta-glucans. Nature (2001) 6.54

In vivo analysis of dendritic cell development and homeostasis. Science (2009) 6.42

A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88

Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity (2006) 5.32

Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27

Serum antibody responses after intradermal vaccination against influenza. N Engl J Med (2004) 4.88

A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol (2006) 4.61

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol (2007) 4.54

Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity (2010) 4.03

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med (2007) 3.64

An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe (2009) 3.52

Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol (2003) 3.39

Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest (2006) 3.31

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med (2009) 3.12

Origin and development of dendritic cells. Immunol Rev (2010) 2.90

Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe (2009) 2.81

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med (2011) 2.78

Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med (2009) 2.77

CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med (2009) 2.75

Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest (2011) 2.66

CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol (2007) 2.61

Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity (2011) 2.58

Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol (2011) 2.34

Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis (2009) 2.33

Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity (2006) 2.20

Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity (2011) 2.12

Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol (2011) 1.98

Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. Immunity (2011) 1.98

The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe (2011) 1.97

Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation. J Immunol (2007) 1.95

CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med (2011) 1.95

Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics (2010) 1.86

Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One (2010) 1.85

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med (2009) 1.84

CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity (2002) 1.83

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood (2011) 1.83

Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci U S A (2009) 1.78

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood (2008) 1.78

Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev (2010) 1.68

Demystifying the development of dendritic cell subtypes, a little. Immunol Cell Biol (2008) 1.60

Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol (2006) 1.58

Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology (2011) 1.51

Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol (2009) 1.48

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med (2001) 1.47

Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J Immunol (2009) 1.47

Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol (2006) 1.41

A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe (2011) 1.41

Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe (2011) 1.36

Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol (2010) 1.33

Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun (2008) 1.30

HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc (2011) 1.29

Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest (2000) 1.27

The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol (2009) 1.27

Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J Immunol (2008) 1.24

Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio (2010) 1.22

Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis (1993) 1.21

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood (2011) 1.18

Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe (2010) 1.13

Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol (1996) 1.08

Universal vaccines: shifting to one for many. MBio (2010) 1.04

Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J Immunol (2005) 1.02

A novel pseudopodial component of the dendritic cell anti-fungal response: the fungipod. PLoS Pathog (2010) 1.00

Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling. J Immunol (2011) 0.99

Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS One (2007) 0.97

Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice. J Clin Invest (2012) 0.96

Dendritic cell-based vaccination against opportunistic fungi. Vaccine (2004) 0.95

Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood (2011) 0.95

A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol (2011) 0.92

CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens. Eur J Immunol (2008) 0.91

Antigen-presenting dendritic cells rescue CD4-depleted CCR2-/- mice from lethal Histoplasma capsulatum infection. Infect Immun (2010) 0.83

Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis. Infect Immun (2011) 0.80

Articles by these authors

Global control of dimorphism and virulence in fungi. Science (2006) 3.50

Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol (2006) 1.58

Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med (2003) 1.58

Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot Cell (2002) 1.29

T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity (2015) 1.29

Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol (2002) 1.22

Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity (2012) 1.17

Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection. J Immunol (2004) 1.16

Linking fungal morphogenesis with virulence. Cell Microbiol (2002) 1.15

Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol (2008) 1.15

Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe (2010) 1.13

A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J Immunol (2011) 1.03

Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun (2011) 1.03

Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia (2002) 1.02

BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J Immunol (2002) 1.01

Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog (2012) 1.01

IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J Immunol (2005) 0.97

Genetic diversity in Blastomyces dermatitidis: implications for PCR detection in clinical and environmental samples. Med Mycol (2010) 0.95

Variation in Pseudonocardia antibiotic defence helps govern parasite-induced morbidity in Acromyrmex leaf-cutting ants. Environ Microbiol Rep (2009) 0.95

SREB, a GATA transcription factor that directs disparate fates in Blastomyces dermatitidis including morphogenesis and siderophore biosynthesis. PLoS Pathog (2010) 0.94

Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay. PLoS One (2012) 0.94

Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol (2013) 0.93

Immunotherapy for fungal infections. Clin Infect Dis (2006) 0.93

Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. J Immunol (2006) 0.92

Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol (2005) 0.90

Calcium binding by the essential virulence factor BAD-1 of Blastomyces dermatitidis. J Biol Chem (2005) 0.90

Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J Immunol (2012) 0.89

V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis. Infect Immun (2006) 0.89

Insights into Fungal Morphogenesis and Immune Evasion: Fungal conidia, when situated in mammalian lungs, may switch from mold to pathogenic yeasts or spore-forming spherules. Microbe Wash DC (2008) 0.86

Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res (2010) 0.85

Identification of the mating-type (MAT) locus that controls sexual reproduction of Blastomyces dermatitidis. Eukaryot Cell (2012) 0.83

Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase. Infect Immun (2011) 0.83

Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence. Infect Immun (2010) 0.82

Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis. Eukaryot Cell (2004) 0.81

CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis. Infect Immun (2005) 0.81

Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection. Infect Immun (2014) 0.81

Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection. J Infect Dis (2013) 0.81

Using new genetic tools to study the pathogenesis of Blastomyces dermatitidis. Trends Microbiol (2002) 0.81

Detection and measurement of two-component systems that control dimorphism and virulence in fungi. Methods Enzymol (2007) 0.80

A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis (2013) 0.79

Complement component 3C3 and C3a receptor are required in chitin-dependent allergic sensitization to Aspergillus fumigatus but dispensable in chitin-induced innate allergic inflammation. MBio (2013) 0.79

Analysis of non-adhesive pathogenic mechanisms of BAD1 on Blastomyces dermatitidis. Med Mycol (2006) 0.78

Isolation of Blastomyces dermatitidis yeast from lung tissue during murine infection for in vivo transcriptional profiling. Fungal Genet Biol (2013) 0.77

Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4+ T cells: robust activation and proliferation with weak effector function during recall. Infect Immun (2011) 0.77

Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol (2011) 0.77

Fungal glycan interactions with epithelial cells in allergic airway disease. Curr Opin Microbiol (2013) 0.76

Aspergillus fumigatus Copper Export Machinery and Reactive Oxygen Intermediate Defense Counter Host Copper-Mediated Oxidative Antimicrobial Offense. Cell Rep (2017) 0.75